Early Phase 1 Lupus Nephritis Clinical Trials
4 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
Safety and Efficacy of ONT01 in Lupus
Systemic Lupus ErythematosusSLELupus Nephritis (LN)+5 more
Hospital for Special Surgery, New York61 enrolled1 locationNCT07107659
Recruiting
Early Phase 1
CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis
Lupus Nephritis
He Huang9 enrolled1 locationNCT06785519
Recruiting
Early Phase 1
Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease
IgG4-related DiseaseLupus Nephritis
Tongji Hospital30 enrolled1 locationNCT06497387
Recruiting
Early Phase 1
Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
IgG4-related DiseaseLupus Nephritis
Tongji Hospital30 enrolled1 locationNCT06497361